ALT - Altimmune - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALT is currently covered by 6 analysts with an average price target of $14.94. This is a potential upside of $11.55 (340.71%) from yesterday's end of day stock price of $3.39.

Altimmune's activity chart (see below) currently has 66 price targets and 83 ratings on display. The stock rating distribution of ALT is 88.89% BUY, 7.41% HOLD and 3.7% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12% with an average time for these price targets to be met of 35.1 days.

Highest price target for ALT is $18, Lowest price target is $1, average price target is $14.2.

Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 13-Aug-2025. First documented stock forecast 01-Jun-2020.

Currently out of the existing stock ratings of ALT, 24 are a BUY (88.89%), 2 are a HOLD (7.41%), 1 are a SELL (3.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$18

$14.46 (408.47%)

$20

12 days ago
(13-Aug-2025)

4/17 (23.53%)

$14.26 (381.28%)

214

Buy

$12

$8.46 (238.98%)

$12

12 days ago
(13-Aug-2025)

0/19 (0%)

$8.26 (220.86%)

Buy

$15

$11.46 (323.73%)

$25

1 months 15 days ago
(10-Jul-2025)

0/16 (0%)

$10.6 (240.91%)

Sell

$1

$-2.54 (-71.75%)

$13

1 months 15 days ago
(10-Jul-2025)

1/4 (25%)

$-3.4 (-77.27%)

34

Buy

$25

$21.46 (606.21%)

$25

1 years 2 months 4 days ago
(21-Jun-2024)

3/14 (21.43%)

$18.59 (290.02%)

42

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALT (Altimmune) average time for price targets to be met?

On average it took 35.1 days on average for the stock forecasts to be realized with a an average price target met ratio 12

Which analyst has the current highest performing score on ALT (Altimmune) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on ALT (Altimmune)?

Mayank Mamtani works at B. RILEY and has 2 price targets and 1 ratings on ALT

Which analyst is the currently most bullish on ALT (Altimmune)?

Roger Song with highest potential upside - $28.34

Which analyst is the currently most reserved on ALT (Altimmune)?

Corinne Jenkins with lowest potential downside - -$2.54

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?